ARZNEIVERABREICHUNGSSYSTEM

Patent europeic · EP4208233 · En vigur

Inscripziun en il register

Numer da publicaziun: EP4208233
Numer da la dumonda: EP21773028
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: En vigur
Scrittira da patent: Concedì
Annunzià: 01-09-2021
Publitgà: 12-07-2023
Concedì: 19-08-2026
La protecziun finescha il pli tard: 31-08-2041
Proxima taxa annuala scadenta: 30-09-2027
Classas IPC: A61M 15/08 (2006.01)
A61M 11/00 (2006.01)
A61M 15/00 (2006.01)
A61J 1/20 (2006.01)
A61K 31/135 (2006.01)
A61K 31/4045 (2006.01)
A61K 31/485 (2006.01)
B05B 11/00 (2023.01)
B05B 11/02 (2023.01)
G16H 20/13 (2018.01)
A61M 16/16 (2006.01)
A61K 9/00 (2006.01)
Prioritad: US 202063073033 P 01.09.2020
Dumonda PCT: PCT/EP2021/074152 01.09.2021
Publicaziun PCT: WO2022/049136 10.03.2022
Lingua da l’annunzia: englais
Funtauna: Swissreg

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

01-10-2026
Next annual fee due on
Next annual fee due on
30.09.2026 → 30.09.2027
Published in Swissreg on 01.10.2026
02-09-2026
Represchentant inscrit
Representative
Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex
Published in Swissreg on 02.09.2026
19-08-2026
Concedì
Specification status
Non-published patent application → Granted patent
Status of protective title
Initiated → Active
Published in Swissreg on 19.08.2026

JANSSEN Pharmaceutica NV

Turnhoutseweg 30, 2340 Beerse, BE

Chemin de l'Echo 3, 1213 Onex